Hundreds of inherited mutations to BRCA1, a high-risk susceptibility gene for breast and ovarian cancer, have been shown to be harmless...
A genetic predisposition to endometriosis may also increase a woman's risk of developing certain types of ovarian cancer, new findings suggest...
Cells in cervical smear test samples could be used as an indicator for breast and ovarian cancer, and show promise as tools for monitoring cancer risk...
Mutations in the FANCI gene have been linked to risks of ovarian cancer for the first time...
Sarah Norcross, director of the Progress Educational Trust, invited the audience of the event to consider where assisted reproductive technologies stood 55 years ago...
A clinical trial combining two cancer therapies has shown promising results in patients with low grade serous ovarian cancer...
Offering healthy people genetic screening could provide clinically important information in over 15 percent of cases...
BRCA2 mutations may be implicated in infertility, as well as increasing cancer risk, according to new research...
Direct-to-consumer genomic testing is a thriving market – for example by June 2020, 23andMe had sold over a quarter of a million testing kits in the UK...
New research suggests mutations in multiple DNA repair genes can determine how well ovarian cancer patients will respond to the PARP inhibitor, rucaparib...
Subscribe for free to what PET does best – informing you of the latest in fertility, genomics and embryo research.
